Foamix Pharmaceuticals Ltd. announced the appointment of Mr. David Domzalski, Foamix’s Chief Executive Officer (CEO), as a member of its board of directors. Mr. Domzalski has 25 years of experience in the pharmaceutical industry. He joined Foamix in 2014 as President of Foamix Pharmaceuticals Inc., and was appointed as the company’s CEO in July of 2017. Mr. Domzalski replaces Dr. Dov Tamarkin, the former CEO and a co-founder of Foamix, who is retiring from the Board after having completed the orderly transition of his managerial duties over the past 6 months.